ChronoScale Corporation reported $12M of revenue over the trailing twelve months, −34% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $12M (to Q3 2026). Net income: −$16M, trailing twelve months to Q3 2026. Free cash flow: −$12M, trailing twelve months to Q3 2026. Operating margin: −158%, trailing twelve months to Q3 2026.

CHRNChronoScale Corporation

Technology

$18.55+320% 1Y

$18.55

$3.8752 weeks$29.82

CHRN as reported

ChronoScale Corporation reported $12M of revenue over the trailing twelve months, −34% on the year before. 10 reported series are charted on this page, each one as filed.

$12M

Revenue, trailing twelve months · to Q3 2026 · −34% against the twelve months before

Net income: −$16M
Net income · +45% year on year · trailing twelve months to Q3 2026
Free cash flow: −$12M
Free cash flow · +45% year on year · trailing twelve months to Q3 2026
Operating margin: −158%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for CHRN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$12M	−34%	Q3 2026
Net income	−$16M	+45%	Q3 2026
EPS	−$5.38	−27%	Q3 2026
Gross margin	51%	n/a	Q3 2026
Operating margin	−158%	n/a	Q3 2026
Net margin	−159%	n/a	Q3 2026
ROE	−272%	n/a	Q3 2026
ROA	−58%	n/a	Q3 2026
ROIC	378%	n/a	Q3 2026
Free cash flow	−$12M	+45%	Q3 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.